Olivia Fromigué

3.7k total citations
60 papers, 3.0k citations indexed

About

Olivia Fromigué is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Olivia Fromigué has authored 60 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Molecular Biology, 23 papers in Oncology and 15 papers in Cancer Research. Recurrent topics in Olivia Fromigué's work include Bone Metabolism and Diseases (18 papers), Bone health and treatments (13 papers) and Mesenchymal stem cell research (11 papers). Olivia Fromigué is often cited by papers focused on Bone Metabolism and Diseases (18 papers), Bone health and treatments (13 papers) and Mesenchymal stem cell research (11 papers). Olivia Fromigué collaborates with scholars based in France, Germany and Spain. Olivia Fromigué's co-authors include Pierre J. Marie, Eric Haÿ, Zahia Hamidouche, Abderrahim Lomri, Jean-Jacques Body, Laurence Lagneaux, Pascal Vaudin, Dominique Modrowski, J.J. Body and Jérôme Lemonnier and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Olivia Fromigué

60 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Olivia Fromigué France	32	1.5k	926	485	467	415	60	3.0k
Geertje van der Horst Netherlands	31	1.9k 1.3×	1.3k 1.4×	362 0.7×	573 1.2×	200 0.5×	46	3.3k
Andrea Del Fattore Italy	30	2.2k 1.4×	970 1.0×	350 0.7×	578 1.2×	374 0.9×	74	3.7k
Su‐Li Cheng United States	32	2.4k 1.5×	682 0.7×	402 0.8×	274 0.6×	338 0.8×	53	4.4k
Chunxi Ge United States	23	1.4k 0.9×	575 0.6×	370 0.8×	363 0.8×	333 0.8×	47	2.4k
Eric Haÿ France	32	1.7k 1.1×	578 0.6×	411 0.8×	305 0.7×	203 0.5×	66	3.0k
Yi Tang United States	23	1.7k 1.1×	740 0.8×	212 0.4×	467 1.0×	212 0.5×	36	2.7k
Abraham Schneider United States	28	1.1k 0.7×	1.4k 1.5×	400 0.8×	294 0.6×	422 1.0×	73	3.3k
Rajaram Gopalakrishnan United States	29	1.7k 1.1×	982 1.1×	329 0.7×	263 0.6×	186 0.4×	80	3.1k
Riccardo Ferracini Italy	33	1.3k 0.8×	872 0.9×	301 0.6×	260 0.6×	185 0.4×	92	3.0k

Countries citing papers authored by Olivia Fromigué

Since Specialization

Citations

This map shows the geographic impact of Olivia Fromigué's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olivia Fromigué with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olivia Fromigué more than expected).

Fields of papers citing papers by Olivia Fromigué

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olivia Fromigué. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olivia Fromigué. The network helps show where Olivia Fromigué may publish in the future.

Co-authorship network of co-authors of Olivia Fromigué

This figure shows the co-authorship network connecting the top 25 collaborators of Olivia Fromigué. A scholar is included among the top collaborators of Olivia Fromigué based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olivia Fromigué. Olivia Fromigué is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Costa, Maria Eugénia Marques Da, Antonin Marchais, Anne Gomez‐Brouchet, et al.. (2019). In-Vitro and In-Vivo Establishment and Characterization of Bioluminescent Orthotopic Chemotherapy-Resistant Human Osteosarcoma Models in NSG Mice. Cancers. 11(7). 997–997. 11 indexed citations

Costa, Maria Eugénia Marques Da, et al.. (2019). MT2A is an early predictive biomarker of response to chemotherapy and a potential therapeutic target in osteosarcoma. Scientific Reports. 9(1). 12301–12301. 16 indexed citations

Vilalta, Marta, et al.. (2014). Cyr61 silencing reduces vascularization and dissemination of osteosarcoma tumors. Oncogene. 34(24). 3207–3213. 21 indexed citations

Dieci, Maria Vittoria, et al.. (2014). Abstract 435: Is PYGM dysregulation involved in breast cancer cell metabolism. Cancer Research. 74(19_Supplement). 435–435. 1 indexed citations

Hamidouche, Zahia, Isabelle Girault, Ana Patiño‐García, et al.. (2013). Zinc chelation: a metallothionein 2A’s mechanism of action involved in osteosarcoma cell death and chemotherapy resistance. Cell Death and Disease. 4(10). e874–e874. 50 indexed citations

Brun, Julia, Caroline Marty, Judith M. Müller, et al.. (2013). FHL2 Silencing Reduces Wnt Signaling and Osteosarcoma Tumorigenesis In Vitro and In Vivo. PLoS ONE. 8(1). e55034–e55034. 36 indexed citations

Fromigué, Olivia, Julia Brun, Caroline Marty, et al.. (2012). Peptide‐based activation of alpha5 integrin for promoting osteogenesis. Journal of Cellular Biochemistry. 113(9). 3029–3038. 42 indexed citations

Brun, Julia, Olivia Fromigué, Caroline Marty, et al.. (2012). The LIM-only protein FHL2 controls mesenchymal cell osteogenic differentiation and bone formation through Wnt5a and Wnt10b. Bone. 53(1). 6–12. 30 indexed citations

Lecourt, Séverine, Jean‐Pierre Marolleau, Olivia Fromigué, et al.. (2010). Characterization of distinct mesenchymal-like cell populations from human skeletal muscle in situ and in vitro. Experimental Cell Research. 316(15). 2513–2526. 68 indexed citations

10.

Hamidouche, Zahia, Olivia Fromigué, Jochen Ringe, Thomas Häupl, & Pierre J. Marie. (2010). Crosstalks between integrin alpha 5 and IGF2/IGFBP2 signalling trigger human bone marrow-derived mesenchymal stromal osteogenic differentiation. BMC Cell Biology. 11(1). 44–44. 71 indexed citations

11.

Hamidouche, Zahia, Olivia Fromigué, Ulrike A. Nuber, et al.. (2010). Autocrine fibroblast growth factor 18 mediates dexamethasone‐induced osteogenic differentiation of murine mesenchymal stem cells. Journal of Cellular Physiology. 224(2). 509–515. 57 indexed citations

12.

Fromigué, Olivia, Eric Haÿ, A. Barbara, & Pierre J. Marie. (2010). Essential Role of Nuclear Factor of Activated T Cells (NFAT)-mediated Wnt Signaling in Osteoblast Differentiation Induced by Strontium Ranelate. Journal of Biological Chemistry. 285(33). 25251–25258. 115 indexed citations

13.

Djouad, Farida, Claire Bony, Olivia Fromigué, et al.. (2009). Transcriptomic Analysis Identifies Foxo3A as a Novel Transcription Factor Regulating Mesenchymal Stem Cell Chrondrogenic Differentiation. Cloning and Stem Cells. 11(3). 407–416. 23 indexed citations

14.

Davidson, Patricia M., Olivia Fromigué, Pierre J. Marie, et al.. (2009). Topographically induced self-deformation of the nuclei of cells: dependence on cell type and proposed mechanisms. Journal of Materials Science Materials in Medicine. 21(3). 939–946. 45 indexed citations

15.

Fromigué, Olivia, Céline Bazille, Natacha Entz‐Werlé, et al.. (2007). Syndecan-2 Affects the Basal and Chemotherapy-Induced Apoptosis in Osteosarcoma. Cancer Research. 67(8). 3708–3715. 40 indexed citations

16.

Fromigué, Olivia, Zahia Hamidouche, Sébastien Chateauvieux, Pierre Charbord, & Pierre J. Marie. (2007). Distinct osteoblastic differentiation potential of murine fetal liver and bone marrow stroma‐derived mesenchymal stem cells. Journal of Cellular Biochemistry. 104(2). 620–628. 15 indexed citations

17.

Fromigué, Olivia, et al.. (2006). Dual involvement of protein kinase C δ in apoptosis induced by syndecan‐2 in osteoblasts. Journal of Cellular Biochemistry. 98(4). 838–850. 17 indexed citations

18.

Fromigué, Olivia, Eric Haÿ, Dominique Modrowski, et al.. (2006). RhoA GTPase inactivation by statins induces osteosarcoma cell apoptosis by inhibiting p42/p44-MAPKs-Bcl-2 signaling independently of BMP-2 and cell differentiation. Cell Death and Differentiation. 13(11). 1845–1856. 102 indexed citations

19.

Fromigué, Olivia, Dominique Modrowski, & Pierre J. Marie. (2005). Apoptosis in Membranous Bone Formation: Role of Fibroblast Growth Factor and Bone Morphogenetic Protein Signaling. Critical Reviews in Eukaryotic Gene Expression. 15(1). 75–92. 8 indexed citations

20.

Haÿ, Eric, Jérôme Lemonnier, Olivia Fromigué, & Pierre J. Marie. (2001). Bone Morphogenetic Protein-2 Promotes Osteoblast Apoptosis through a Smad-independent, Protein Kinase C-dependent Signaling Pathway. Journal of Biological Chemistry. 276(31). 29028–29036. 148 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact